Sample Reports | Old Reports | Not Current

Flexigroup (ASX:FXL)
Speculative
medium
H
To New Chapters Fiscal 2018 was a solid year for consumer credit player, FlexiGroup (ASX:FXL), which reported marked improvements across key metrics, supported by the prudent retirement of legacy brands (instead of pointlessly holding on) and replacing them with more ‘relevant’ brands. While the shares have yet to perform, we remain encouraged by the company’s outlook under new leadership. What’s New? Our last coverage of the stock was in March (FAT-AUS-864) where we focussed on the company’s interim results which showed that it
Bank of Queensland (ASX:BOQ)
Core
medium
B
Staying with Queensland The initial investor response to Bank of Queensland’s FY18 results was positive. Although the results were a mixed bag; the key cash earnings metric was higher than expected and net interest margins expanded. We also like the relative “flexibility” advantage the bank offers. Valuations in the sector are undemanding after a period of negative sentiment. The Royal Commission highlighted many aspects of bad behaviour in the financial industry, although the focus was generally on the larger players. Bank of
ANZ Banking Group (ASX:ANZ)
Core
medium
B
Getting serious about customer compensation ANZ (ASX:ANZ) shares dipped 2.6% yesterday after the bank flagged its FY18 cash earnings will be impacted by substantial charges for customer compensation and other significant items. The charges highlight that the aftermath of the Royal Commission will be expensive, but given the correction in ANZ shares, we believe significant “bad news” has already been priced in and the bar for outperformance going forward set relatively low. The Royal Commission has highlighted many instances of bad behaviour
Collins Foods (ASX:CKF)
Core
medium
B
Going for a Third Bite It seems that the third time is indeed the charm, with Taco Bell’s latest attempt to launch in Australia having early success. The country’s largest KFC operator, Collins Foods (ASX:CKF), has announced plans to roll-out the Mexican offering across three states over the next three years. With attractive growth prospects for a ‘defensive’ stock, we maintain our BUY rating on Collins. What’s New? Last month (FAT-AUS-890), we covered the company’s Annual General Meeting wherein management provided more colour
Woodside Petroleum (ASX:WPL)
Core
medium
B
A solid half all round Woodside Petroleum (ASX:WPL) reported an improvement in its first half underlying profit for 2018. The company announced a surge in sales revenue, as production and oil prices delivered for the half. The balance sheet reaped the benefit of the financial performance for the half, to step further up the quality scale. Shareholders received a boost in the interim dividend. The following table shows a summary of the company’s first half result (in US Dollars): Source: Woodside petroleum
Incitec Pivot (ASX:IPL)
Speculative
high
B
Things are Picking Up Shares of Incitec Pivot (ASX:IPL) have staged a solid recovery from 52-week lows in recent months. The backdrop for end markets is improving in our view, with inflationary pressures likely to continue flowing through to commodity prices. In addition, following the reporting of interim results, Incitec Pivot reported a contract win in West Australia that will mitigate the earlier loss of two other contracts. The company also inked a deal for gas supply to the Gibson Island
IMF Bentham (ASX:IMF)
Speculative
medium
B
A Case for Bulls Litigation Financier, IMF Bentham (ASX:IMF) has finished the year in the middle of its 5-year transformation towards a “fund manager” business model where it will manage third party capital in its Special Purpose Vehicle funds. Naturally, the transformation will show some “growing pains” while the legacy business model reflects the historical issues of lumpy returns. Nevertheless, we are pleased with the company’s progress so far and maintain our BUY rating. What’s New? In our previous coverage of the company
Sonic Healthcare (ASX:SHL)
Core
medium
H
In Good Health Diagnostics and pathology giant Sonic Healthcare (ASX:SHL) delivered a solid set of 2018 fiscal results, with healthy revenue and profit growth, although management have flagged a more cautious outlook for the current year outlook. Nonetheless, the company provides a blend of defensive and growth characteristics with a strong track record for shareholders. Accordingly, we recommend holding the stock. FY18 review Group revenue for the year increased 8.2% to $5.54 billion, benefitting from a slight foreign exchange rate tailwind. In constant


About these archived stock reports

These are archived Fat Prophets equity research stock reports and share analysis. They do not constitute current investment advice, financial product advice, or a recommendation to buy, sell or hold any financial product. They are provided for historical reference only, and reflect the market conditions, company information, forecasts and opinions available at its original publication date. The information may no longer be current or applicable. Past performance is not a reliable indicator of future performance.

This is general information only and does not take into account your objectives, financial situation or needs. Before acting on anything in this report, you should consider its appropriateness to your circumstances and seek advice from a licensed financial adviser.

DISCLAIMER Fat Prophets has made every effort to ensure the reliability of the views and recommendations expressed in the reports published on its websites. Fat Prophets research is based upon information known to us or which was obtained from sources which we believed to be reliable and accurate at time of publication. However, like the markets, we are not perfect. This report is prepared for general information only, and as such, the specific needs, investment objectives or financial situation of any particular user have not been taken into consideration. Individuals should therefore discuss, with their financial planner or advisor, the merits of each recommendation for their own specific circumstances and realise that not all investments will be appropriate for all subscribers. To the extent permitted by law, Fat Prophets and its employees, agents and authorised representatives exclude all liability for any loss or damage (including indirect, special, or consequential loss or damage) arising from the use of, or reliance on, any information within the report whether or not caused by any negligent act or omission. If the law prohibits the exclusion of such liability, Fat Prophets hereby limits its liability, to the extent permitted by law, to the resupply of the said information or the cost of the said resupply.

Funds Management – In addition to the listed fund FPC, Fat Prophets Pty Ltd manages the separately managed accounts, namely Concentrated Australian Shares, Australian Shares Income, Small Midcap, Global Opportunities, Mining & Resources, and Asian Shares. These SMAs are managed under their own mandates by the fund managers, and this is independent to the research reports.

Staff trading – Fat Prophets Pty Ltd, its directors, employees and associates of Fat Prophets may hold interests in many ASX-listed Australian companies which may or may not be mentioned or recommended in the Fat Prophets newsletter. These positions may change at any time, without notice. To manage the conflict between personal dealing and newsletter recommendations the directors, employees, and associates of Fat Prophets Pty Ltd cannot knowingly trade in a stock 48 hours either side of a buy or sell recommendation being made in the Fat Prophets newsletter. Staff trades are pre-approved by an appointed staff trading compliance officer to ensure compliance with the staff trading policy.

For positions that directors and/or associates of the Fat Prophets group of companies currently hold in, please click here.

Agree to Fat Prophets Terms and Conditions to Access

This legacy Fat Prophets content is provided for transparency and educational or historical reference only. It reflects the information, market conditions, opinions, and analysis available at the time of publication and may no longer be current or applicable. It should not be relied upon as current investment advice.

By clicking “I Agree”, you confirm that you have read, understood and fully agree to the Fat Prophets Terms and Conditions, including the Limitation of Liability.

Fat Prophets Logo

Stock Disclosure

ASX- Listed Australian Stocks:
29M.AU, ANN.AU, ANZ.AU, BPT.AU, BWP.AU, CKF.AU, CBA.AU, EVN.AU, FID.AU, FMG.AU, GOR.AU, GMG.AU, GNC.AU, HUB.AU, ILU.AU, IGO.AU, JHX.AU, MGR.AU, NAB.AU, PAR.AU, QBE.AU, RRL.AU, S32.AU, SBM.AU, TLS.AU, TUA.AU, WES.AU, WBC.AU, WHC.AU, XRO.AUX, AGL.AX, AMC.AX, BHP.AX, CSL.AX, DMP.AX, GDG.AX, WIRE.AX, ATOM.AX, MQG.AX, NIC.AX, NST.AX, ORI.AX, PDN.AX, RMS.AX, RPL.AX, SFR.AX, STO.AX, SUN.AX, VAU.AX, WTC.AX, WDS.AX, GMD.AX, CSC.AX, RIO.AX, GTK.AX, SPK.AX & NEM.AX

International Stocks:
BIDU.CN, 9888.CN, 1211.CN, 268.CN, 3690.HK, 1818.HK, 9618.CN, ENX.FR, BT.A.GB, GENI.GB, FRES.GB, 9988.HK, 2282.HK, 700.HK, 1128.HK, 1876.HK, 8750, 7011.T, 8306.JP, 8031.T, 8411.T, 3994.T, 7974.T, 8604.JP, 8308, 6758.JP, 8316.JP, 8331.T, JP.8308, HEM.SE, GRAB.SG, BABA.K, GOOG.US, AAPL.US, CDE.US, CPNG.K, FLTRF.L, SIL, URA, BZ.O, MSFT.US, SBSW.K, 2840.HK, TME, GDX, GDXJ.US, YUMC.K, Z.O, IMPUY & ANGPY